Sign up to save your podcasts
Or
Share Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis
Treatment of chronic hepatitis C with interferon alpha (IFN-alpha) is relatively contraindicated in patients with psychiatric disorders because of possible severe psychiatric side effects. We report on a case of a female patient with a chronic schizoaffective psychosis, who was treated for 3 months with 3 x 3 mio IE IFN-alpha s.c./week because of a chronic hepatitis C (genotype Ib). Psychosis was stable with flupentixol monotherapy. After 2 months, she developed a severe depressive syndrome which lead to suicidal ideation. Until this time, she was without any antidepressive medication. Depressive symptoms disappeared after interferon therapy was stopped. Under prophylactic treatment with low-dose trimipramine (50 mg) or nefazodone (200 mg/day) therapy with IFN-alpha 3 x 3 mio IE/week was re-established after several months and again 2 years later adding ribavirin 1200 mg/day, a virustaticum. In contrast to the symptoms during monotherapy with IFN-alpha, during the time of both combination treatments, no psychiatric side effects occurred. While for ribavirin antidepressant effects are not known, we suppose that antidepressants may in serotonergic or noradrenergic caused by IFN-alpha. prevent changes neurotransmission caused by IFN-alpha. Copyright (C) 2000 S. Karger AG, Basel.
View all episodes
By Ludwig-Maximilians-Universität MünchenTreatment of chronic hepatitis C with interferon alpha (IFN-alpha) is relatively contraindicated in patients with psychiatric disorders because of possible severe psychiatric side effects. We report on a case of a female patient with a chronic schizoaffective psychosis, who was treated for 3 months with 3 x 3 mio IE IFN-alpha s.c./week because of a chronic hepatitis C (genotype Ib). Psychosis was stable with flupentixol monotherapy. After 2 months, she developed a severe depressive syndrome which lead to suicidal ideation. Until this time, she was without any antidepressive medication. Depressive symptoms disappeared after interferon therapy was stopped. Under prophylactic treatment with low-dose trimipramine (50 mg) or nefazodone (200 mg/day) therapy with IFN-alpha 3 x 3 mio IE/week was re-established after several months and again 2 years later adding ribavirin 1200 mg/day, a virustaticum. In contrast to the symptoms during monotherapy with IFN-alpha, during the time of both combination treatments, no psychiatric side effects occurred. While for ribavirin antidepressant effects are not known, we suppose that antidepressants may in serotonergic or noradrenergic caused by IFN-alpha. prevent changes neurotransmission caused by IFN-alpha. Copyright (C) 2000 S. Karger AG, Basel.
More shows like Medizin - Open Access LMU - Teil 12/22
View all
Center for Advanced Studies (CAS) Research Focus Evolutionary Biology (LMU) - HD
0 Listeners
Hegel lectures by Robert Brandom, LMU Munich
6 Listeners
MCMP – Philosophy of Science
1 Listeners
MCMP – Epistemology
0 Listeners
MCMP – Mathematical Philosophy (Archive 2011/12)
6 Listeners
Sommerfeld Theory Colloquium (ASC)
2 Listeners
Theoretical Physics Schools (ASC)
2 Listeners
MCMP – Philosophy of Mind
0 Listeners
Women Thinkers in Antiquity and the Middle Ages - SD
0 Listeners
NANO-BIO-PHYSICS SYMPOSIUM 06.09.2019 Day 1
0 Listeners